biolab tb 500 bpc 157 TB-500 BPC-157 5mg+5mg Biote Medical - BPC 1000 mcg ml SELECT VOLUME DISCOUNT:5 PACK ~Pre-Order 8-16 week etd
Biote Medical - BPC 157 - Practitioner-Grade Nutraceuticals - Muscle Maintenance + Gut Health (60 Capsules) Health, Household and Personal Care
Not intended for human or animal use, ingestion, or injection
1000 mcg ml
SELECT VOLUME DISCOUNT:5 PACK ~Pre-Order 8-16 week etd
Suomalainen: nothing to disclose, Sami Curtze: nothing to disclose, Tuomas Lumikari: nothing to disclose, Jani Pirinen: nothing to disclose, Daniel Gordin: nothing to disclose, Petra Ijäs: nothing to disclose, Sija Räty: nothing to disclose, Mika Lehto: nothing to disclose, Jukka Putaala: nothing to disclose E-Posters - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.06 - CARDIOEMBOLISM & HEART-BRAIN INTERACTIONS P2371 - ESOC25-1381 STROKE UNIT TELEMETRY REVEALS DISTINCT EPISODE DYNAMICS ASSOCIATED WITH ATRIAL FIBRILLATION BURDEN AFTER ACUTE ISCHEMIC STROKE Markus Klammer 1,2,3 , Helena Stengl 1,2,3 , Alexander Nelde 1,3 , Maximilian Schöls 1,3 , Andreas Meisel 1,2,3 , Franziska Scheibe 1,4 , Christian Nolte 1,2,3 , Matthias Endres, Christian Meisel 2,3,4 , Jan Scheitz 1,2,3 1 Department of Experimental Neurology - Charite Universitätsmedizin Berlin, Berlin, Germany, 2 Center of Stroke Research Berlin, Berlin, Germany, 3 Berlin Institute of Health (BIH), Berlin, Germany, 4 NeuroCure Cluster of Excellence, Charité-Universitätsmedizin Berlin, Berlin, Germany Background and Aims: Atrial fibrillation (AF) burden is a key prognostic factor for AF-related first and recurrent stroke, but its characteristics and AF-associated heart rate (HR) in the early post-stroke phase are not well understood
